Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Beyond efficacy: Ensuring safety in peptide therapeutics
Essentially, Ipamorelin is the short-term trigger for the pituitary to release growth hormone, whereas the CJC-1295 is a much longer-term trigger (with raised hormone levels for as much as 6 to 10 days after administration) The Benifits CJC1295 Increased levels of energy, and better energy metabolism, with decreased fatigue Decreased body fat More easily maintained existing muscle mass, and increased ease to gain new lean muscle mass Higher rates of cellular repair, replication, and regeneration, making it easier to heal from injuries and boosting the immune system Greater bone mineral content, which can be effective at offsetting or decreasing the risk of osteoporosis Improved sleep quality Ipamorelin Increased levels of energy, and better energy metabolism, with decreased fatigue Decreased body fat More easily maintained existing muscle mass, and increased ease to gain new lean muscle mass Higher rates of cellular repair, replication, and regeneration, making it easier to heal from injuries and boosting the immune system Greater bone mineral content, which can be effective at offsetting or decreasing the risk of osteoporosis Improved sleep quality
The mechanism involves suppression of reactive oxygen species (ROS) that the enteric nervous system uses to trigger peristaltic contractions, combined with microbiome shifts away from butyrate-producing bacteria
Follow-Up Appointments Schedule your follow-up sessions as recommended
Further Reading For additional peer-reviewed research, see: AHK-Cu hair follicle study by Pyo et al
Balasubramanian, S
US$ 25.04
US$ 23.26
US$ 20.78
US$ 28.20
US$ 20.52
US$ 25.37
